Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-1291P (RNA, U6 small nuclear 1291, pseudogene) is a pseudogene version of the U6 small nuclear RNA gene, classified as a non-coding RNA pseudogene[1][2]. The parental U6 small nuclear RNA is a component of the spliceosome essential for pre-mRNA splicing, but pseudogenes like RNU6-1291P typically do not produce functional RNA products[5][1]. Pseudogenes may have regulatory effects via acting as miRNA decoys, generation of small RNAs, or influencing gene expression of their parental genes, but no specific evidence for these roles exists for RNU6-1291P[6]. There are no known direct disease associations, drug interactions, or clinical biomarker implications for this specific pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1291, pseudogene (RNU6-1291P).